Ekso Bionics Holdings Inc
NASDAQ:EKSO

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Watchlist
Price: 8.22 USD -4.42% Market Closed
Market Cap: 27.9m USD

Operating Margin

-73.7%
Current
Improving
by 9.5%
vs 3-y average of -83.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-73.7%
=
Operating Income
$-10.9m
/
Revenue
$14.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-73.7%
=
Operating Income
$-10.9m
/
Revenue
$14.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Ekso Bionics Holdings Inc
NASDAQ:EKSO
27.9m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
210.6B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
126.4B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.7B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37B USD
Loading...
No Stocks Found

Market Distribution

Lower than 84% of companies in the United States of America
Percentile
16th
Based on 14 112 companies
16th percentile
-73.7%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Ekso Bionics Holdings Inc
Glance View

Market Cap
27.9m USD
Industry
Health Care

Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in Richmond California, California and currently employs 45 full-time employees. The company went IPO on 2013-04-10. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The firm operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.

EKSO Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-73.7%
=
Operating Income
$-10.9m
/
Revenue
$14.7m
What is Ekso Bionics Holdings Inc's current Operating Margin?

The current Operating Margin for Ekso Bionics Holdings Inc is -73.7%, which is above its 3-year median of -83.2%.

How has Operating Margin changed over time?

Over the last 3 years, Ekso Bionics Holdings Inc’s Operating Margin has increased from -116.5% to -73.7%. During this period, it reached a low of -120.5% on Dec 31, 2022 and a high of -58.4% on Dec 31, 2024.

Back to Top